Funding

Excalipoint Therapeutics

China · Biotech · Healthtech

Develops next-generation T-cell engager therapies for cancer and autoimmune diseases

Visit excalipoint.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed+$27.7M5Y Capital — Role not disclosedApricot Capital — Role not disclosedCenturium Capital — Role not disclosedEisai Innovation Inc — Role not disclosedLAV — Role not disclosedMPCi — Role not disclosed

Investors

5Y CapitalSeed+Apricot CapitalSeed+Centurium CapitalSeed+Eisai Innovation IncSeed+LAVSeed+MPCiSeed+

Coverage

Mar 18, 2026Excalipoint Therapeutics · Seed+

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesexcalipoint.com ↗